Nov 13, 2018 9:05am EST Avalon GloboCare Provides Third Quarter 2018 Business Update; Reports 30% Increase in Revenues
Oct 15, 2018 8:00am EDT Avalon GloboCare Announces Grand Opening of Newly Renovated Headquarters in New Jersey
Oct 09, 2018 9:00am EDT Avalon GloboCare Teams Up with Weill Cornell Medicine to Co-develop Standardization of cGMP-Grade Exosome Isolation and Application of Tissue-Specific Exosomes
Sep 20, 2018 8:00am EDT Avalon GloboCare Commences Operation of its Core GMP Platform, Epicon Biotech, to Facilitate Clinical Development of Cellular Therapies
Aug 15, 2018 8:00am EDT Avalon GloboCare Provides Second Quarter 2018 Business Update; Reports 32% Increase in Revenues
Aug 14, 2018 7:30am EDT Avalon GloboCare Appoints Dr. James L. Gajewski, Former Medical Director at M.D. Anderson Cancer Center, to Head Scientific and Clinical Advisory Board
Aug 07, 2018 7:30am EDT Avalon GloboCare Forms Strategic Partnership with Weill Cornell Medical College to Co-develop Technologies and Bio-production of CAR-T Therapy
Jul 31, 2018 7:30am EDT Avalon GloboCare Appoints Prominent Life Science M&A Attorney Steven Sanders to the Board of Directors
Jul 18, 2018 7:30am EDT Avalon GloboCare Announces Plans to Accelerate Commercialization of Proprietary CAR-T Technologies through Launch of Wholly Owned Subsidiary - Avactis Biosciences